Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension

SONG Jiemei; WEN Xiaoan; SUN Hongbin

doi:10.11665/j.issn.1000-5048.20130101

SONG Jiemei, WEN Xiaoan, SUN Hongbin. Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2013, 44(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20130101

Citation:

SONG Jiemei, WEN Xiaoan, SUN Hongbin. Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2013, 44(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20130101

Citation:

SONG Jiemei, WEN Xiaoan, SUN Hongbin. Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2013, 44(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20130101

Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension

Graphical Abstract

Abstract

Abstract

Pulmonary arterial hypertension(PAH) is a progressive and fatal disease,characterized by elevated pulmonary vascular resistance and pulmonary arterial pressure,most often resulting in right-sided heart failure.The mechanisms of action,approved PAH therapies and the latest agents in late-stage clinical development were reviewed and described in this paper.

FullText(HTML)

References (0)

Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension

Abstract

Catalog

Export File

Citation

Format

Content